"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about IRBESARTAN
• Ask Community about IRBESARTAN
• Read More Here
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

IRBESARTAN Safety Questions, IRBESARTAN Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about IRBESARTAN. Our extensive database of IRBESARTAN adverse events and IRBESARTAN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about IRBESARTAN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

IRBESARTAN Safety Reports

Total IRBESARTAN reports: 124.
IRBESARTAN FDA safety alerts: No.
Reported deaths: 10    Reported hospitalizations: 93.
Take IRBESARTAN Side Effects Survey or Share Your IRBESARTAN Story. Read More Here.

Showing 1-75 of 124 Next >

Consumer or non-health professional from FRANCE reported IRBESARTAN problem on Jan 10, 2005. Female patient, 66 years of age, weighting 257.9 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: haematoma infection. IRBESARTAN dosage: unknown. Patient was hospitalized. Patient died.

IRBESARTAN problem was reported by a Health Professional from ARGENTINA on Jan 13, 2006. Female patient, 79 years of age, was diagnosed with cardiac failure and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac failure, hepatomegaly, pulmonary oedema, renal failure. IRBESARTAN dosage: unknown. During the same period patient was treated with FUROSEMIDE, ACENOCOUMAROL, DIGOXIN, SPIRONOLACTONE, CARVEDILOL, METFORMIN. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on Jan 16, 2006. Female patient, 56 years of age, weighting 220.5 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypersensitivity. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, OFLOXACIN. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on Feb 07, 2005. Female patient, 70 years of age, weighting 189.6 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: accidental overdose, epistaxis, gastrointestinal haemorrhage, international normalised ratio increased, puncture site haemorrhage. IRBESARTAN dosage: unknown. During the same period patient was treated with ACENOCOUMAROL. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on Sept 27, 2006. Male patient, 80 years of age, weighting 187.4 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: renal failure. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, DIGOXIN, DOBUTREX, DIURETIC, BETA BLOCKER. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on June 20, 2006. Male patient, 89 years of age, weighting 183.0 lb, was diagnosed with hypertension, prophylaxis, cardiac disorder, prostatic disorder and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: gastroenteritis, renal failure, retroperitoneal haematoma, therapeutic agent toxicity. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, DIGOXIN, WARFARIN, CARVEDILOL, FINASTERIDE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported IRBESARTAN problem on Nov 08, 2006. Female patient, 79 years of age, weighting 149.9 lb, was diagnosed with essential hypertension, pain, myocardial ischaemia, angina pectoris, oesophageal disorder and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state, dizziness, hyponatraemia, inappropriate antidiuretic hormone secretion, polydipsia. IRBESARTAN dosage: unknown. During the same period patient was treated with TRAMADOL, CARBAMAZEPINE, FUROSEMIDE, FELODIPINE, SOLPRIN, METOPROLOL TARTRATE, TRANSDERM, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Female patient, 70 years of age, was diagnosed with cardiac failure and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea. IRBESARTAN dosage: unknown. During the same period patient was treated with TOPROL, LASIX, LEXAPRO, COUMADIN, RANITIDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported IRBESARTAN problem on Apr 28, 2006. Female patient, 73 years of age, weighting 108.0 lb, was diagnosed with hypertension and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: neck pain, palpitations, tachycardia. IRBESARTAN dosage: FORM IS 150 MG/12.5 MG ONE TABLET DAILY.. During the same period patient was treated with IBUPROFEN. Patient recovered.

IRBESARTAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2006. Female patient, 48 years of age, weighting 160.9 lb, was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: dizziness, gout, pruritus, rash, urticaria. IRBESARTAN dosage: unknown. During the same period patient was treated with PROGESTERONE. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on June 29, 2006. Female patient, 77 years of age, weighting 127.9 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: confusional state, international normalised ratio increased, ischaemic stroke, renal failure acute, renal impairment. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, CLOPIDOGREL BISULPHATE, ASPIRIN, ENALAPRIL MALEATE, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Female patient, 70 years of age, was diagnosed with cardiac failure and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea. IRBESARTAN dosage: unknown. During the same period patient was treated with TOPROL, LASIX, LEXAPRO, COUMADIN, RANITIDINE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on Sept 27, 2006. Male patient, 80 years of age, weighting 187.4 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: arteriovenous fistula operation, renal failure, sepsis. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, DIGOXIN, DOBUTREX, DIURETIC, BETA BLOCKER, NEXIUM, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on Aug 04, 2006. Female patient, 77 years of age, weighting 88.18 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: bronchiectasis, pneumonia, renal impairment, upper respiratory tract infection. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, CEFOBID, AZITHROMYCIN, HEPARIN, ACETAMINOPHEN, CIPROFLOXACIN, BISOLVON. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on June 20, 2006. Male patient, 89 years of age, weighting 183.0 lb, was diagnosed with hypertension, prophylaxis, cardiac disorder, prostatic disorder and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: gastroenteritis, renal failure, retroperitoneal haematoma, therapeutic agent toxicity. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, DIGOXIN, WARFARIN, CARVEDILOL, FINASTERIDE, FOLIC ACID. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on Nov 04, 2005. Male patient, 73 years of age, weighting 127.9 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: dizziness, hypotension. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, ANTICOAGULANT, CARVEDILOL, ZESTRIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported IRBESARTAN problem on Dec 12, 2006. Female patient, 64 years of age, weighting 238.1 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: asthma. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on May 25, 2005. Male patient, 77 years of age, weighting 152.1 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: eczema. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN. Patient recovered.

Consumer or non-health professional from FRANCE reported IRBESARTAN problem on Sept 16, 2004. Female patient, 67 years of age, weighting 119.0 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, haemorrhage urinary tract, nausea, renal failure. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, TIAZAC. Patient was hospitalized and became disabled. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on June 20, 2006. Male patient, 89 years of age, weighting 183.0 lb, was diagnosed with hypertension, prophylaxis, cardiac disorder, prostatic disorder and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, arthralgia, blood creatinine increased, blood electrolytes abnormal, blood glucose increased, blood urea increased, cardiac failure congestive, cardio-respiratory arrest, dehydration. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, DIGOXIN, WARFARIN, CARVEDILOL, FINASTERIDE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on July 03, 2007. Male patient, 80 years of age, weighting 187.4 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: arteriovenous fistula operation, inguinal hernia repair, renal failure, sepsis. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, ASPIRIN, DIGOXIN, DOBUTREX, NEXIUM, PERINDOPRIL ERBUMINE, LANOXIN. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on July 09, 2007. Male patient, 67 years of age, weighting 293.2 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: post procedural haematoma, pyelonephritis. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, PLAVIX, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Physician from KOREA, REPUBLIC OF reported IRBESARTAN problem on July 06, 2007. Male patient, 62 years of age, was diagnosed with hypertension and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: cardioplegia. IRBESARTAN dosage: unknown. During the same period patient was treated with PLAVIX, INDOBUFEN, AMLODIPINE, CARVEDILOL. Patient died on 10/02/2006.

IRBESARTAN problem was reported by a Health Professional from FRANCE on June 29, 2007. Female patient, 76 years of age, weighting 213.8 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, ENALAPRIL, HYDROCHLOROTHIAZIDE, CARVEDILOL, RANITIDINE, LACTULONA. Patient was hospitalized. Patient recovered.

Health Professional from SWITZERLAND reported IRBESARTAN problem on July 09, 2007. Male patient, child 12 years of age, was diagnosed with hypertension and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia. IRBESARTAN dosage: unknown. During the same period patient was treated with AMLODIPINE, METOPROLOL SUCCINATE. Patient recovered.

IRBESARTAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 12, 2007. Male patient, 59 years of age, was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: cold agglutinins positive. IRBESARTAN dosage: unknown. During the same period patient was treated with IOPIDINE. Patient recovered.

Physician from AUSTRALIA reported IRBESARTAN problem on July 17, 2007. Female patient, 55 years of age, weighting 169.8 lb, was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: arthritis, diarrhoea, dry mouth, dysphagia, dyspnoea, fatigue, fluid retention, hot flush, pain in extremity. IRBESARTAN dosage: unknown. During the same period patient was treated with TELFAST. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on July 27, 2007. Female patient, 59 years of age, weighting 209.4 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: renal failure. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, LASIX, CIPROFLOXACIN, AMLODIPINE, LISINOPRIL, METFORMIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported IRBESARTAN problem on July 31, 2007. Male patient, 59 years of age, was diagnosed with hypertension and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: cold agglutinins positive. IRBESARTAN dosage: unknown. During the same period patient was treated with IOPIDINE. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from AUSTRALIA on Aug 02, 2007. Male patient, 75 years of age, weighting 165.3 lb, was diagnosed with essential hypertension, depression and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: balance disorder, hyponatraemia, inappropriate antidiuretic hormone secretion, renal impairment. IRBESARTAN dosage: unknown. During the same period patient was treated with MIRTAZAPINE, BRICANYL, ASPIRIN, NEXIUM, VOLTAREN. Patient was hospitalized. Patient recovered.

Health Professional from reported IRBESARTAN problem on Aug 07, 2007. Female patient, 24 years of age, was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, pregnancy, renal aplasia. IRBESARTAN dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, CALCIUM SUPPLEMENT, IRON SUPPLEMENT, EPOGEN, LEVOTHYROXINE, INSULIN. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on Aug 07, 2007. Female patient, 81 years of age, weighting 165.3 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: brain neoplasm malignant, haemorrhagic stroke. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, CORTICOSTEROID. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from SPAIN reported IRBESARTAN problem on Aug 07, 2007. Female patient, 24 years of age, weighting 134.5 lb, was diagnosed with hypertension and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital central nervous system anomaly, pregnancy, renal aplasia. IRBESARTAN dosage: unknown. During the same period patient was treated with INSULIN GLARGINE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE. Patient recovered.

IRBESARTAN problem was reported by a Consumer or non-health professional from FRANCE on Aug 01, 2007. Male patient, 80 years of age, weighting 116.8 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, sepsis. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, DIGOXIN. Patient was hospitalized and became disabled. Patient died on 07/24/2007.

Health Professional from AUSTRALIA reported IRBESARTAN problem on Aug 16, 2007. Male patient, 75 years of age, weighting 165.3 lb, was diagnosed with essential hypertension, depression and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: balance disorder, hyponatraemia, inappropriate antidiuretic hormone secretion, renal impairment. IRBESARTAN dosage: unknown. During the same period patient was treated with MIRTAZAPINE, BRICANYL, ASPIRIN, NEXIUM, VOLTAREN. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Consumer or non-health professional from FRANCE on Aug 15, 2007. Male patient, 81 years of age, weighting 147.7 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: colonic polyp. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported IRBESARTAN problem on Aug 09, 2007. Male patient, 80 years of age, weighting 116.8 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, sepsis. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, DIGOXIN. Patient was hospitalized and became disabled. Patient died on 07/24/2007.

IRBESARTAN problem was reported by a Health Professional from SWITZERLAND on Aug 20, 2007. Female patient, 77 years of age, weighting 132.3 lb, was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: mixed hepatocellular-cholestatic injury. IRBESARTAN dosage: unknown. During the same period patient was treated with LASIX, MARCUMAR, CONCOR, CALCIMAGON, CHONDROSULF. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on Aug 21, 2007. Male patient, 74 years of age, weighting 377.0 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastroduodenal ulcer, international normalised ratio increased, pneumonia, pyrexia, shock haemorrhagic, upper gastrointestinal haemorrhage. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, COUMADIN, INDOCIN, TOPROL, LISINOPRIL. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on Aug 22, 2007. Male patient, 81 years of age, was diagnosed with cardiac failure and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: renal failure. IRBESARTAN dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on Aug 23, 2007. Male patient, 74 years of age, weighting 377.0 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastroduodenal ulcer, international normalised ratio increased, pneumonia, pyrexia, shock haemorrhagic. IRBESARTAN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, ASPIRIN, COUMADIN, INDOCIN, TOPROL, LISINOPRIL. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from FRANCE on Aug 27, 2007. Male patient, 74 years of age, weighting 377.0 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastroduodenal ulcer, international normalised ratio increased, pneumonia, pyrexia, shock haemorrhagic, upper gastrointestinal haemorrhage. IRBESARTAN dosage: unknown. During the same period patient was treated with COUMADIN, CLOPIDOGREL BISULPHATE, ASPIRIN, INDOCIN, TOPROL, LISINOPRIL, LASIX. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on Aug 29, 2007. Male patient, 74 years of age, weighting 377.0 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastroduodenal ulcer, gouty arthritis, international normalised ratio increased, pneumonia, pyrexia, shock haemorrhagic, upper gastrointestinal haemorrhage. IRBESARTAN dosage: unknown. During the same period patient was treated with COUMADIN, CLOPIDOGREL BISULPHATE, ASPIRIN, INDOCIN, TOPROL, LISINOPRIL, LASIX. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Consumer or non-health professional from NORWAY on Aug 30, 2007. Female patient, 75 years of age, was diagnosed with cardiac failure and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, renal failure. IRBESARTAN dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported IRBESARTAN problem on Aug 31, 2007. Female patient, 59 years of age, weighting 209.4 lb, was diagnosed with hypertension, prophylaxis and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: renal failure. IRBESARTAN dosage: unknown. During the same period patient was treated with WARFARIN, LASIX, CIPROFLOXACIN, AMLODIPINE, LISINOPRIL, METFORMIN. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Consumer or non-health professional from NORWAY on Sept 07, 2007. Female patient, 87 years of age, was diagnosed with cardiac failure and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: dehydration, renal failure. IRBESARTAN dosage: unknown. During the same period patient was treated with MAREVAN, CENTYL, ISOPTIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from NORWAY reported IRBESARTAN problem on Sept 07, 2007. Female patient, 75 years of age, was diagnosed with cardiac failure and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, renal failure. IRBESARTAN dosage: unknown. Patient was hospitalized. Patient recovered.

IRBESARTAN problem was reported by a Health Professional from UNITED KINGDOM on Sept 17, 2007. Female patient, 35 years of age, weighting 224.9 lb, was diagnosed with hypertension and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: menorrhagia. IRBESARTAN dosage: unknown. During the same period patient was treated with PARACETAMOL. Patient recovered.

Health Professional from UNITED STATES reported IRBESARTAN problem on Sept 17, 2007. Male patient, 82 years of age, was diagnosed with convulsion and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: akinesia, dementia, hypertonia, muscle rigidity, tremor. IRBESARTAN dosage: unknown. During the same period patient was treated with FUROSEMIDE, MEMANTINE, VALPROIC ACID. Patient was hospitalized. Patient recovered.

Showing 1-75 of 124 Next >

Ask Our Patient Community about IRBESARTAN
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil (lisinopril) Procrit (epoetin alfa) ProHance (gadoteridol) Promethazine Propofol Prosom (estazolam) Protonix (pantoprazole) Protopic (tacrolimus) Provigil (modafinil) Prozac (fluoxetine) Prussian blue back to top	Q Quazepam Quetiapine Quinapril Quinupristin R Rabeprazole Radiogardase (prussian blue) Ramelteon Ramipril Ranexa (ranolazine) Ranibizumab Ranolazine Rapamune (sirolimus) Raptiva (efalizumab) Rasagiline Razadyne (galantamine) Rebetol (ribavirin) Reclast (zoledronic acid) Refludan (lepirudin recombinant) Relenza (zanamivir) Relpax (eletriptan) Remeron